ClinicalTrials.govpublic full text
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
hiv infection, antiretroviral therapy, lentivirus infections, two drugs regimen, renal safety, neuropsychiatric adverse events, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 991856
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.